268 related articles for article (PubMed ID: 24703100)
1. Clear cell papillary renal cell carcinoma: micro-RNA expression profiling and comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma.
Munari E; Marchionni L; Chitre A; Hayashi M; Martignoni G; Brunelli M; Gobbo S; Argani P; Allaf M; Hoque MO; Netto GJ
Hum Pathol; 2014 Jun; 45(6):1130-8. PubMed ID: 24703100
[TBL] [Abstract][Full Text] [Related]
2. Targeted next-generation sequencing and non-coding RNA expression analysis of clear cell papillary renal cell carcinoma suggests distinct pathological mechanisms from other renal tumour subtypes.
Lawrie CH; Larrea E; Larrinaga G; Goicoechea I; Arestin M; Fernandez-Mercado M; Hes O; Cáceres F; Manterola L; López JI
J Pathol; 2014 Jan; 232(1):32-42. PubMed ID: 24155122
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA expression profiling of Xp11 renal cell carcinoma.
Marchionni L; Hayashi M; Guida E; Ooki A; Munari E; Jabboure FJ; Dinalankara W; Raza A; Netto GJ; Hoque MO; Argani P
Hum Pathol; 2017 Sep; 67():18-29. PubMed ID: 28411178
[TBL] [Abstract][Full Text] [Related]
4. Clear Cell Papillary Renal Cell Carcinoma Shares Distinct Molecular Characteristics and may be Significantly Associated With Higher Risk of Developing Second Primary Malignancy.
Tian X; Xu WH; Wu JL; Gan HL; Wang HK; Gu WJ; Qu YY; Zhang HL; Ye DW
Pathol Oncol Res; 2021; 27():1609809. PubMed ID: 34512202
[TBL] [Abstract][Full Text] [Related]
5. Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution.
Dhakal HP; McKenney JK; Khor LY; Reynolds JP; Magi-Galluzzi C; Przybycin CG
Am J Surg Pathol; 2016 Feb; 40(2):141-54. PubMed ID: 26752401
[TBL] [Abstract][Full Text] [Related]
6. Clear cell papillary renal cell carcinoma and renal angiomyoadenomatous tumor: two variants of a morphologic, immunohistochemical, and genetic distinct entity of renal cell carcinoma.
Deml KF; Schildhaus HU; Compérat E; von Teichman A; Storz M; Schraml P; Bonventre JV; Fend F; Fleige B; Nerlich A; Gabbert HE; GaBler N; Grobholz R; Hailemariam S; Hinze R; Knüchel R; Lhermitte B; Nesi G; Rüdiger T; Sauter G; Moch H
Am J Surg Pathol; 2015 Jul; 39(7):889-901. PubMed ID: 25970683
[TBL] [Abstract][Full Text] [Related]
7. Application of Chromosome Microarray Analysis for the Differential Diagnosis of Low-grade Renal Cell Carcinoma With Clear Cell and Papillary Features.
Pei J; Al-Saleem T; Uzzo RG; Dulaimi E; Testa JR; Wei S
Appl Immunohistochem Mol Morphol; 2020 Feb; 28(2):123-129. PubMed ID: 32044880
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of Clear Cell Papillary Renal Cell Carcinoma (ccpRCC).
Rysz J; Franczyk B; Ławiński J; Gluba-Brzózka A
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008576
[TBL] [Abstract][Full Text] [Related]
9. Cytomorphologic analysis of clear cell papillary renal cell carcinoma: Distinguishing diagnostic features.
Griffin BB; Lin X
Cancer Cytopathol; 2021 Mar; 129(3):192-203. PubMed ID: 33036062
[TBL] [Abstract][Full Text] [Related]
10. Clear cell papillary renal cell carcinoma-like tumors in patients with von Hippel-Lindau disease are unrelated to sporadic clear cell papillary renal cell carcinoma.
Williamson SR; Zhang S; Eble JN; Grignon DJ; Martignoni G; Brunelli M; Wang M; Gobbo S; Baldridge LA; Cheng L
Am J Surg Pathol; 2013 Aug; 37(8):1131-9. PubMed ID: 23648463
[TBL] [Abstract][Full Text] [Related]
11. The Clinicopathologic and Molecular Landscape of Clear Cell Papillary Renal Cell Carcinoma: Implications in Diagnosis and Management.
Weng S; DiNatale RG; Silagy A; Mano R; Attalla K; Kashani M; Weiss K; Benfante NE; Winer AG; Coleman JA; Reuter VE; Russo P; Reznik E; Tickoo SK; Hakimi AA
Eur Urol; 2021 Apr; 79(4):468-477. PubMed ID: 33046271
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c.
Nakada C; Matsuura K; Tsukamoto Y; Tanigawa M; Yoshimoto T; Narimatsu T; Nguyen LT; Hijiya N; Uchida T; Sato F; Mimata H; Seto M; Moriyama M
J Pathol; 2008 Dec; 216(4):418-27. PubMed ID: 18925646
[TBL] [Abstract][Full Text] [Related]
13. New mechanistic insights of clear cell renal cell carcinoma from integrated miRNA and mRNA expression profiling studies.
Qi Y; Wang L; Wang K; Peng Z; Ma Y; Zheng Z; Shang D; Xu W; Zheng J
Biomed Pharmacother; 2019 Mar; 111():821-834. PubMed ID: 30616081
[TBL] [Abstract][Full Text] [Related]
14. MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: a comparison of primary tumors and distant metastases.
Heinzelmann J; Unrein A; Wickmann U; Baumgart S; Stapf M; Szendroi A; Grimm MO; Gajda MR; Wunderlich H; Junker K
Ann Surg Oncol; 2014 Mar; 21(3):1046-54. PubMed ID: 24242678
[TBL] [Abstract][Full Text] [Related]
15. Noncoding RNA Expression and Targeted Next-Generation Sequencing Distinguish Tubulocystic Renal Cell Carcinoma (TC-RCC) from Other Renal Neoplasms.
Lawrie CH; Armesto M; Fernandez-Mercado M; Arestín M; Manterola L; Goicoechea I; Larrea E; Caffarel MM; Araujo AM; Sole C; Sperga M; Alvarado-Cabrero I; Michal M; Hes O; López JI
J Mol Diagn; 2018 Jan; 20(1):34-45. PubMed ID: 29056573
[TBL] [Abstract][Full Text] [Related]
16. miRNA-target network reveals miR-124as a key miRNA contributing to clear cell renal cell carcinoma aggressive behaviour by targeting CAV1 and FLOT1.
Butz H; Szabó PM; Khella HW; Nofech-Mozes R; Patocs A; Yousef GM
Oncotarget; 2015 May; 6(14):12543-57. PubMed ID: 26002553
[TBL] [Abstract][Full Text] [Related]
17. miR-141 is a key regulator of renal cell carcinoma proliferation and metastasis by controlling EphA2 expression.
Chen X; Wang X; Ruan A; Han W; Zhao Y; Lu X; Xiao P; Shi H; Wang R; Chen L; Chen S; Du Q; Yang H; Zhang X
Clin Cancer Res; 2014 May; 20(10):2617-30. PubMed ID: 24647573
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA profiles classify papillary renal cell carcinoma subtypes.
Wach S; Nolte E; Theil A; Stöhr C; T Rau T; Hartmann A; Ekici A; Keck B; Taubert H; Wullich B
Br J Cancer; 2013 Aug; 109(3):714-22. PubMed ID: 23799849
[TBL] [Abstract][Full Text] [Related]
19. MiRNA-9 and MiRNA-200a distinguish hemangioblastomas from metastatic clear cell renal cell carcinomas in the CNS.
Venneti S; Boateng LA; Friedman JR; Baldwin DA; Tobias JW; Judkins AR; Mourelatos Z; Lal P
Brain Pathol; 2012 Jul; 22(4):522-9. PubMed ID: 22082152
[TBL] [Abstract][Full Text] [Related]
20. Clear cell papillary renal cell carcinoma in patients with von Hippel-Lindau syndrome--clinicopathological features and comparative genomic analysis of 3 cases.
Rao P; Monzon F; Jonasch E; Matin SF; Tamboli P
Hum Pathol; 2014 Sep; 45(9):1966-72. PubMed ID: 25081542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]